← Evidence map

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Predictable Clinical Benefits without Evidence of Synergy in Trials of Combination Therapies with Immune-Checkpoint Inhibitors.

Adam C Palmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

43 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35045958